SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-073612
Filing Date
2018-03-07
Accepted
2018-03-07 16:37:08
Documents
6
Effectiveness Date
2018-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 d545328ds8.htm S-8 50298
2 EX-5.1 d545328dex51.htm EX-5.1 16996
3 EX-23.1 d545328dex231.htm EX-23.1 1430
4 EX-23.2 d545328dex232.htm EX-23.2 1428
5 GRAPHIC g545328g0307132359803.jpg GRAPHIC 1799
6 GRAPHIC g545328g38s97.jpg GRAPHIC 3127
  Complete submission text file 0001193125-18-073612.txt   78254
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-223491 | Film No.: 18673789
SIC: 2834 Pharmaceutical Preparations